Cargando…
Efficacy and safety of pulsatile gonadotropin-releasing hormone therapy in patients with congenital hypogonadotropic hypogonadism: a multicentre clinical study
BACKGROUND: Pulsatile gonadotropin-releasing hormone (GnRH) therapy may restore function of the hypothalamus-pituitary-gonad axis and induce spermatogenesis in male patients with congenital hypogonadotropic hypogonadism (CHH). The study sought to test the reliability of a newly developed Innopump(®)...
Autores principales: | Hao, Ming, Mao, Jiang-Feng, Guan, Qing-Bo, Tian, Long, Han, Hu, Lei, Hong-En, Zheng, Dong-Mei, Tian, Zhen-Hua, Nie, Min, Wang, Xi, Yu, Bing-Qing, Gao, Yin-Jie, Wu, Xue-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267282/ https://www.ncbi.nlm.nih.gov/pubmed/34277762 http://dx.doi.org/10.21037/atm-21-1632 |
Ejemplares similares
-
Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism
por: Mao, Jiang-Feng, et al.
Publicado: (2017) -
Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients
por: Hao, Ming, et al.
Publicado: (2019) -
The initiation and maintenance of gonadotropin-releasing hormone neuron identity in congenital hypogonadotropic hypogonadism
por: Chung, Wilson CJ, et al.
Publicado: (2023) -
Gonadotropin-Releasing Hormone Receptor (GnRHR) and Hypogonadotropic Hypogonadism
por: Fanis, Pavlos, et al.
Publicado: (2023) -
Spermatogenesis of Male Patients with Congenital Hypogonadotropic Hypogonadism Receiving Pulsatile Gonadotropin-Releasing Hormone Therapy Versus Gonadotropin Therapy: A Systematic Review and Meta-Analysis
por: Wei, Chao, et al.
Publicado: (2021)